A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. (2023)

First Author: Swen JJ
Attributed to:  Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(22)01841-4

PubMed Identifier: 36739136

Publication URI: http://europepmc.org/abstract/MED/36739136

Type: Journal Article/Review

Volume: 401

Parent Publication: Lancet (London, England)

Issue: 10374

ISSN: 0140-6736